AZYTER

This brand name is authorized in Austria, Cyprus, Finland, France, Hong Kong, Croatia, Ireland, Netherlands, Poland, Romania, Tunisia, Turkey, United Kingdom

Active ingredients

The drug AZYTER contains one active pharmaceutical ingredient (API):

1 Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE

Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation. Read about Azithromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AA26	Azithromycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 400839
Country: FR	Base de données publique des médicaments	Identifier(s): 69326767
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 193724
Country: HK	Department of Health Drug Office	Identifier(s): 60515
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-422626992
Country: IE	Health Products Regulatory Authority	Identifier(s): 13113
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 86975
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100181487
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56936001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8443081
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680177220054